rs104894286
Variant summary
Our verdict is Pathogenic. The variant received 15 ACMG points: 15P and 0B. PM2PM5PP2PP3_ModeratePP5_Very_Strong
The NM_000448.3(RAG1):c.2210G>A(p.Arg737His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000285 in 1,614,178 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 13/22 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R737C) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000448.3 missense
Scores
Clinical Significance
Conservation
Publications
- Omenn syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, G2P, Orphanet
- recombinase activating gene 2 deficiencyInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positiveInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 15 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| RAG1 | NM_000448.3 | c.2210G>A | p.Arg737His | missense_variant | Exon 2 of 2 | ENST00000299440.6 | NP_000439.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152174Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000398 AC: 10AN: 251392 AF XY: 0.0000294 show subpopulations
GnomAD4 exome AF: 0.0000287 AC: 42AN: 1461886Hom.: 0 Cov.: 36 AF XY: 0.0000206 AC XY: 15AN XY: 727242 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152292Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74470 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive Pathogenic:3
- -
The missense variant NM_000448.3(RAG1):c.2210G>A, p.(Arg737His) was identified in a compound heterozygous state in a proband diagnosed with SCID in Russian pilot NBS project covering more than 200,000 newborns. This variant has been previously reported in the literature multiple times (PMIDs: 9630231, 11971977, 24290284) and is listed in gnomAD v2.1.1 eleven times, exclusively in heterozygous individuals. The affected amino acid position is evolutionarily conserved, and multiple in silico prediction tools support a deleterious effect. Furthermore, functional studies have demonstrated a damaging impact on RAG1 activity (PMID: 28783691). Taken together, the variant meets the following ACMG/AMP criteria and can be classified as pathogenic with PM2, PP3, PS1, PS3, PP5, PP4 criteria. -
The NM_000448.3:c.2210G>A variant in the RAG1 gene results in a missense mutation (p.Arg737His), substituting arginine with histidine at a critical position within the protein’s core domain. RAG1 is essential for V(D)J recombination, a process that generates diverse antigen receptors in B and T cells. This variant disrupts recombinase activity, leading to defective lymphocyte development and function. Clinically, it has been associated with autosomal recessive severe combined immunodeficiency (SCID) and Omenn syndrome, both characterized by profound immunodeficiency, eosinophilia, and autoimmunity. Its absence in population databases and deleterious functional impact support its classification as pathogenic in the germline context.Sanger sequencing confirmed variant presence. -
Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;C1835931:Combined immunodeficiency due to partial RAG1 deficiency;C2673536:Combined immunodeficiency with skin granulomas;C2700553:Histiocytic medullary reticulosis Pathogenic:1
- -
Histiocytic medullary reticulosis Pathogenic:1
- -
Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;C2673536:Combined immunodeficiency with skin granulomas Pathogenic:1
This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 737 of the RAG1 protein (p.Arg737His). This variant is present in population databases (rs104894286, gnomAD 0.02%). This missense change has been observed in individual(s) with severe combined immunodeficiency and Omenn syndrome (PMID: 9630231, 17572155, 28109013, 30290665, 30858051). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is also known as G2322A and c.2322G>A. ClinVar contains an entry for this variant (Variation ID: 13149). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on RAG1 protein function. Experimental studies have shown that this missense change affects RAG1 function (PMID: 9630231). For these reasons, this variant has been classified as Pathogenic. -
not provided Pathogenic:1
- -
Inherited Immunodeficiency Diseases Pathogenic:1
- -
Combined immunodeficiency due to partial RAG1 deficiency Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at